1[1]Desport JC,Preux PM,Truong CT, et al.Nutritional assessment and survival in ALS patients.Amyotroph Lateral Scler Other Motor Neuron Disord,2000,Mar,1(2):91～96
2[2]Victor M,Ropper AH.Syndrome of muscular weakness and wasting without sensory changes.In:Victor M,Ropper AH:Adams and Victor's Principles of Neurology.McGraw-Hill,Inc,7th,2001:1152～1158
3[3]Borasio GD,Miller RG.Clinical characteristics and management of ALS.Seminars in Neurology,2001,21(2):155～166
4[4]Pioro EP.Antioxidant therapy in ALS.Amyotroph Lateral Scler Other Motor Neuron Disord,2000 Dec,1:5-12.
5[5]Desnuelle C,Dib M,Garrel C,et al.A double-blind,placebo-controlled randomized clinical trial of alpha-tocopherol(vitamin E) in the treatment of amyotrophic lateral sclerosis.ALS riluzole-tocopherol Study Group.Amyotroph Lateral Scler Other Motor Neuron Disord,2001 Mar,2(1):9-18
6[6]Bromberg MB.Pathogenesis of amyotrophic lateral sclerosis:a critical review.Curr OPin Neurol,1999,12(5):581～588
7[7]Garter GT,Rosen BS.Marijuana in the management of amyotrophic lateral sclerosis.Am J Hosp Palliat Care,2001,18(4):264～270
8[8]Appel SH,Beers D,Smith RG,et al.ALtered calcuim homeostasis in ALS as a target for therapy.Amyotroph Lateral Scler Other Motor Neuron Disord,2000 Dec;1 Beers D:27-32
9[9]Gelinas DF.Riruzole Amyotroph Lateral Scler Ohter Motor Neuron Disord,2000 Dec;1:3～4
10[10]Derby ML,Giuliano R,Figlewicz DA,et al.GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase(SOD-1) gene.Amyotroph Lateral Scler Ohter Motor Neuron Disord,2000 Mar;1(2):113-122
6Gelinas DF,Riruzole.Amyotroph lateral scler other motor neuron disord[J].Neurology,2000,1:3-4.
7Appel SH,Beers D,Smith RG.Altered calcium homeostasis in ALS as a target for therapy[J].Amyotroph Lateral Scler Other Motor Neuron Disord,2000,1:27-32.
